SCHEMBL22133064

SCHEMBL22133064

CC(C)(C)OC(=O)N[C@@H](CC12CC3CC(CC(C3)C1)C2)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPFFR1 Q9GZQ6 1/20 0.45
▸ NPFFR2 Q9Y5X5 1/20 0.45
▸ REN P00797 2/20 0.45
▸ PSMB8 P28062 1/20 0.44
▸ PSMB9 P28065 1/20 0.44
▸ PSMB5 P28074 1/20 0.44
▸ OPRM1 P35372 3/20 0.44
▸ ERAP2 Q6P179 2/20 0.44
▸ ERAP1 Q9NZ08 2/20 0.44
▸ LNPEP Q9UIQ6 2/20 0.44
▸ CCKBR P32239 1/20 0.44
▸ NPY4R P50391 5/20 0.43
▸ NPY1R P25929 2/20 0.43
▸ NPY2R P49146 2/20 0.43
▸ NPY5R Q15761 2/20 0.43
▸ OPRK1 P41145 2/20 0.42
▸ CTSS P25774 2/20 0.42
▸ CTSL P07711 1/20 0.42
▸ CTSB P07858 1/20 0.42
▸ CTSK P43235 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22133070 1.00 NPFFR1 (0.45) NPFFR1NPFFR2RENPSMB8PSMB9
SCHEMBL22117451 0.94 PSMB8 (0.46) NPFFR1NPFFR2RENPSMB8PSMB9
SCHEMBL22117454 0.94 PSMB8 (0.46) NPFFR1NPFFR2RENPSMB8PSMB9
SCHEMBL28633963 0.92 NPFFR1 (0.43) NPFFR1NPFFR2RENPSMB8PSMB9
SCHEMBL28633961 0.92 NPFFR1 (0.43) NPFFR1NPFFR2RENPSMB8PSMB9
SCHEMBL30341836 0.92 PSMB8 (0.47) NPFFR1NPFFR2RENPSMB8PSMB9
SCHEMBL30341831 0.92 KLK7 (0.49) NPFFR1NPFFR2PSMB8PSMB9PSMB5
SCHEMBL31679039 0.92 KLK7 (0.49) NPFFR1NPFFR2PSMB8PSMB9PSMB5
SCHEMBL22117497 0.90 NPFFR1 (0.47) NPFFR1NPFFR2OPRM1ERAP2ERAP1
SCHEMBL22117495 0.90 NPFFR1 (0.47) NPFFR1NPFFR2OPRM1ERAP2ERAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12404300-B2 Mitochondria-targeting peptides STEALTH BIOTHERAPEUTICS INC. (US) 2025-09-02 — — US disclosed
WO-2020131282-A1 MITOCHONDRIA-TARGETING PEPTIDES STEALTH BIOTHERAPEUTICS CORP. (MC) 2020-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12404300-B2 Mitochondria-targeting peptides SSBP1, HSPE1, IMMT NPFFR1 2526/4885NPFFR2 2690/4885REN 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback